B. Riley Financial Issues Pessimistic Forecast for Core Scientific (NASDAQ:CORZ) Stock Price

Core Scientific (NASDAQ:CORZ – Get Free Report) had its price target lowered by equities researchers at B. Riley Financial from $31.00 to $27.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently has a “buy” rating on the stock. B. Riley Financial‘s target price would suggest a potential upside of 105.64% from the stock’s current price.

CORZ has been the topic of a number of other research reports. Needham & Company LLC dropped their price objective on shares of Core Scientific from $35.00 to $28.00 and set a “buy” rating on the stock in a research note on Friday, November 6th. Rothschild & Co Redburn began coverage on shares of Core Scientific in a research note on Monday, September 21st. They issued a “neutral” rating and a $16.00 target price for the company. Cantor Fitzgerald reissued an “overweight” rating and set a $39.00 price target on shares of Core Scientific in a report on Wednesday, October 14th. Canaccord Genuity Group restated a “buy” rating and set a $36.00 price target on shares of Core Scientific in a research report on Thursday, October 15th. Finally, UBS Group reiterated a “market outperform” rating on shares of Core Scientific in a research report on Wednesday, October 14th. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $30.32.

Get Our Latest Analysis on CORZ

Core Scientific Stock Up 3.2%

Shares of CORZ opened at $13.13 on Monday. Core Scientific has a 52 week low of $10.59 and a 52 week high of $30.46. The company has a market capitalization of $4.23 billion, a price-to-earnings ratio of 48.92 and a beta of 5.56. The stock’s 50-day moving average price is $15.54 and its 200-day moving average price is $19.43.

Core Scientific (NASDAQ:CORZ – Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of ($0.05) by $0.52. The firm had revenue of $232.87 million for the quarter, compared to analyst estimates of $196.54 million. Core Scientific had a negative return on equity of 70.05% and a negative net margin of 18.31%. As a group, equities analysts anticipate that Core Scientific will post -1.36 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Eric Weiss purchased 7,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was bought at an average price of $19.19 per share, with a total value of $134,330.00. Following the acquisition, the director owned 259,262 shares in the company, valued at $4,975,237.78. The trade was a 2.77% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Todd M. Duchene sold 10,000 shares of the company’s stock in a transaction on Monday, October 26th. The stock was sold at an average price of $13.56, for a total transaction of $135,600.00. Following the transaction, the insider owned 1,133,286 shares of the company’s stock, valued at $15,367,358.16. This represents a 0.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have bought 19,000 shares of company stock worth $342,290 and have sold 90,000 shares worth $1,428,900. Company insiders own 1.70% of the company’s stock.

Institutional Trading of Core Scientific

Several large investors have recently bought and sold shares of the business. BlackRock Inc. acquired a new stake in Core Scientific during the second quarter worth about $719,649,000. Bank of America Corp DE grew its stake in shares of Core Scientific by 412.5% in the 1st quarter. Bank of America Corp DE now owns 4,806,363 shares of the company’s stock valued at $71,903,000 after buying an additional 3,868,535 shares during the period. Apollo Management Holdings L.P. acquired a new stake in shares of Core Scientific during the 2nd quarter worth approximately $115,671,000. Fifth Third Bancorp acquired a new stake in shares of Core Scientific during the 1st quarter worth approximately $59,802,000. Finally, Avala Global LP acquired a new stake in shares of Core Scientific during the 2nd quarter worth approximately $101,729,000.

About Core Scientific

(Get Free Report)

Core Scientific, Inc. is a U.S.-based digital infrastructure company that operates data centers and provides computing services. Its business includes mining bitcoin, which involves using specialized computers to help process transactions and secure the Bitcoin network, as well as hosting equipment for third-party mining customers. The company also provides data center infrastructure for high-performance computing workloads, including artificial intelligence applications. Its facilities and services are designed to support the power, cooling, and computing needs of these operations.

Further Reading

Analyst Recommendations for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.